Cargando…
Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia
Dihydrofolate reductase (DHFR) has an important function in DNA synthesis and is a target of methotrexate, which is a crucial treatment option for acute lymphoblastic leukemia (ALL). However, the number of studies conducted to date on DHFR expression in childhood ALL is limited. The aim of the prese...
Autores principales: | Organista-Nava, Jorge, Gómez-Gómez, Yazmín, Illades-Aguiar, Berenice, Rivera-Ramírez, Ana Bertha, Saavedra-Herrera, Mónica Virginia, Leyva-Vázquez, Marco Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950508/ https://www.ncbi.nlm.nih.gov/pubmed/29805575 http://dx.doi.org/10.3892/ol.2018.8429 |
Ejemplares similares
-
High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia
por: ORGANISTA-NAVA, JORGE, et al.
Publicado: (2015) -
Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia
por: Organista-Nava, Jorge, et al.
Publicado: (2019) -
Plasma levels of YKL-40 as a prognostic factor in childhood acute lymphoblastic leukemia
por: Rivas-Alarcón, Alinne Ayulieth, et al.
Publicado: (2021) -
Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer
por: Organista-Nava, Jorge, et al.
Publicado: (2019) -
Effect of folylpolyglutamate synthase A22G polymorphism on the risk and survival of patients with acute lymphoblastic leukemia
por: GÓMEZ-GÓMEZ, YAZMÍN, et al.
Publicado: (2014)